Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Patient derived orthotopic xenograft models of medulloblastoma lack a functional blood brain barrier
Author: Genovesi, L.A.
Puttick, S.
Millar, A.
Kojic, M.
Ji, P.
Lagendijk, A.K.
Brighi, C.
Bonder, C.S.
Adolphe, C.
Wainwright, B.J.
Citation: Neuro-Oncology, 2021; 23(5):732-742
Publisher: Oxford University Press
Issue Date: 2021
ISSN: 1522-8517
Statement of
Laura A. Genovesi, Simon Puttick, Amanda Millar, Marija Kojic, Pengxiang Ji, Anne K. Lagendijk, Caterina Brighi, Claudine S. Bonder, Christelle Adolphe, and Brandon J. Wainwright
Abstract: Background: Novel targeted therapies for children diagnosed with medulloblastoma (MB), the most common malignant pediatric brain tumor, are urgently required. A major hurdle in the development of effective therapies is the impaired delivery of systemic therapies to tumor cells due to a specialized endothelial blood-brain barrier (BBB). Accordingly, the integrity of the BBB is an essential consideration in any preclinical model used for assessing novel therapeutics. This study sought to assess the functional integrity of the BBB in several preclinical mouse models of MB. Methods: Dynamic contrast enhancement (DCE) magnetic resonance imaging (MRI) was used to evaluate blood-brain tumour-barrier (BBTB) permeability in a murine genetically engineered mouse model (GEMM) of SHH MB, patient-derived orthotopic xenograft (PDOX) models of MB (SHH and Gp3) and orthotopic transplantation of GEMM tumor cells, enabling a comparison of the direct effects of transplantation on the integrity of the BBTB. Immunofluorescence analysis was performed to compare the structural and sub-cellular features of tumor-associated vasculature in all models. Results: Contrast enhancement was observed in all transplantation models of MB. No contrast enhancement was observed in the GEMM despite significant tumor burden. Cellular analysis of BBTB integrity revealed aberrancies in all transplantation models, correlating to the varying levels of BBTB permeability observed by MRI in these models. Conclusions: These results highlight functional differences in the integrity of the BBTB and tumor vessel phenotype between commonly utilised preclinical models of MB, with important implications for the preclinical evaluation of novel therapeutic agents for MB.
Keywords: Blood-brain barrier; magnetic resonance imaging; medulloblastoma; patient-derived xenograft models; vasculature
Rights: © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail:
DOI: 10.1093/neuonc/noaa266
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.